Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Total Non-Current Liabilities (2021 - 2024)

HealthLynked (HLYK) has disclosed Total Non-Current Liabilities for 4 consecutive years, with $5.3 million as the latest value for Q4 2024.

  • Quarterly Total Non-Current Liabilities changed N/A to $5.3 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $5.3 million through Dec 2024, changed N/A year-over-year, with the annual reading at $5.3 million for FY2024, N/A changed from the prior year.
  • Total Non-Current Liabilities for Q4 2024 was $5.3 million at HealthLynked, up from $4.1 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $5.3 million in Q4 2024, with the low at $2.7 million in Q4 2021.
  • Average Total Non-Current Liabilities over 4 years is $4.0 million, with a median of $4.0 million recorded in 2023.
  • Peak annual rise in Total Non-Current Liabilities hit 53.89% in 2022, while the deepest fall reached 53.89% in 2022.
  • Over 4 years, Total Non-Current Liabilities stood at $2.7 million in 2021, then skyrocketed by 53.89% to $4.2 million in 2022, then dropped by 1.05% to $4.1 million in 2023, then increased by 28.8% to $5.3 million in 2024.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $5.3 million, $4.1 million, and $3.9 million for Q4 2024, Q3 2023, and Q2 2023 respectively.